Team:EPF-Lausanne/Playground

From 2011.igem.org

(Difference between revisions)
Line 15: Line 15:
We used a microfluidic based approach for characterizing TF mutants in vitro. The MITOMI method allows us to measure absolute binding affinities and specificities of transcription factors (Cite the science paper). We determined the precise binding energy landscape of the wild type TetR transcription factor. We also generated several TetR transcription factor mutants and determined the specificities of a number of the new variants.
We used a microfluidic based approach for characterizing TF mutants in vitro. The MITOMI method allows us to measure absolute binding affinities and specificities of transcription factors (Cite the science paper). We determined the precise binding energy landscape of the wild type TetR transcription factor. We also generated several TetR transcription factor mutants and determined the specificities of a number of the new variants.
</div>
</div>
 +
 +
<div class=frontpagebox odd">
 +
<h2>In vivo TF characterization</h2>
 +
 +
To be able to determine the in vivo activity and specificity of novel transcription factor variants we generated a suite of reporter plasmid systems. We successfully characterized a number of our reporter systems for functionality. We created a number of reporter plasmids to measure TetR activity, which lead to improved characterization data for the Partsregistry.
 +
</div>
 +
 +
<div class="frontpagebox odd">
 +
<h2>Microfluidics</h2>
 +
 +
We noticed that only a small number of iGEM teams have also made use of microfluidics in the past. Because we think that microfluidics is a useful tool for the iGEM community, we decided to promote the techique by creating a live online microfluidics game: from any web browser, you can control the setup located in our lab in Lausanne. In addition, we wrote a guide on the wiki to help future teams get started with these techniques.
 +
</html>
</html>
{{:Team:EPF-Lausanne/Templates/Footer}}
{{:Team:EPF-Lausanne/Templates/Footer}}

Revision as of 18:25, 20 September 2011